Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Edwards

Showing results (1-10 of 196) with videos related to

Pageof 20
Sort By:
Lupus|June 11, 2020
Hydroxychloroquine and coronavirus disease 19Christopher J Edwards
Rheumatology (Oxford, England)|May 5, 2021
How important is JAK1 selectivity?Christopher J Edwards
The Journal of Rheumatology|August 2, 2008
Commensal gut bacteria and the etiopathogenesis of rheumatoid arthritisChristopher J Edwards
Rheumatology (Oxford, England)|September 9, 2011
IL-6 inhibition and infection: treating patients with tocilizumabChristopher J Edwards
British Medical Bulletin|September 22, 2005
Immunological therapies for rheumatoid arthritisChristopher J Edwards
RMD Open|November 4, 2022
Free educational material on the EULAR school of rheumatology websiteChristopher J Edwards
The Journal of Rheumatology|December 31, 2009
Can the events of early life influence the development of rheumatoid arthritis?Christopher J Edwards
Rheumatology (Oxford, England)|March 14, 2023
Treat to target in RA: how strict should we be in the pursuit of remission?Christopher J Edwards
Rheumatology (Oxford, England)|October 9, 2025
The presence of synovial inflammation and response to targeted therapiesChristopher J Edwards
Joint Bone Spine|February 26, 2026
Is Methotrexate still a first-line treatment in Rheumatoid arthritis?Sayna Bahrani, Christopher J Edwards
Pageof 20

Showing results (1-10 of 196) with videos related to

Sort By:
Pageof 20
Lupus|June 11, 2020
Hydroxychloroquine and coronavirus disease 19Christopher J Edwards
Rheumatology (Oxford, England)|May 5, 2021
How important is JAK1 selectivity?Christopher J Edwards
The Journal of Rheumatology|August 2, 2008
Commensal gut bacteria and the etiopathogenesis of rheumatoid arthritisChristopher J Edwards
Rheumatology (Oxford, England)|September 9, 2011
IL-6 inhibition and infection: treating patients with tocilizumabChristopher J Edwards
British Medical Bulletin|September 22, 2005
Immunological therapies for rheumatoid arthritisChristopher J Edwards
RMD Open|November 4, 2022
Free educational material on the EULAR school of rheumatology websiteChristopher J Edwards
The Journal of Rheumatology|December 31, 2009
Can the events of early life influence the development of rheumatoid arthritis?Christopher J Edwards
Rheumatology (Oxford, England)|March 14, 2023
Treat to target in RA: how strict should we be in the pursuit of remission?Christopher J Edwards
Rheumatology (Oxford, England)|October 9, 2025
The presence of synovial inflammation and response to targeted therapiesChristopher J Edwards
Joint Bone Spine|February 26, 2026
Is Methotrexate still a first-line treatment in Rheumatoid arthritis?Sayna Bahrani, Christopher J Edwards
Pageof 20